Citable company snapshot
CME Group's latest SEC-sourced 2026-06-30 period shows $1.71B in revenue and $1.04B in net income.
| Metric | Latest period | Latest value | Prior value | YoY |
|---|---|---|---|---|
| Revenue | Jun 30, 2026 | $1.71B | $1.88B | -9.2% |
| Operating Income | Jun 30, 2026 | $1.11B | $1.31B | -15.5% |
| Net Income | Jun 30, 2026 | $1.04B | $1.17B | -10.8% |
| Operating Cash Flow (computed) | Jun 30, 2026 | $947.10M | $1.26B | -24.8% |
| Free Cash Flow (computed) | Jun 30, 2026 | $923.50M | $1.24B | -25.4% |
Source: SEC EDGAR financial statements; period Jun 30, 2026; filed Jul 24, 2026; accession 0001156375-26-000047.
CME company research is available with Aerarium Pro (CAD $10/mo). The five showcase tickers (TSLA, NVDA, AAPL, AMZN, PLTR) and the macro dashboard stay free. Already a subscriber? Sign in to pick up where you left off.